Ignite Creation Date:
2024-05-06 @ 8:29 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06394674
Status:
RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-04-27
Brief Title:
High-dose Furmonertinib in the Treatment in Patients With Advanced Metastatic NSCLC With Progressed After First- or Second-line Treatment With Osimertinib
Sponsor:
Changhai Hospital
Organization:
Changhai Hospital
Organization Data
Organization:
Changhai Hospital
Class:
OTHER
Study ID:
CHEC2023-155
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Changhai Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Second Affiliated Hospital of Wannan Medical College | OTHER |
| The General Hospital of Eastern Theater Command | OTHER |
| Shanghai Chest Hospital | OTHER |
| Fujian Provincial Hospital | OTHER |
| Shanghai Changzheng Hospital | OTHER |
| First Affiliated Hospital Bengbu Medical College | OTHER |
| The First Peoples Hospital of Changzhou | OTHER |